CD8A and neoplasm: It is known that RT increases the expression of PD-L1 and promotes anti-tumor immunity [93], therefore, it is reasonable to think that, in the era of immunotherapy, the combination of PD-L1 and CD8 expression may have an important predictive response value [94].